India approves Takeda's Qdenga dengue vaccine for domestic use

India's drug regulator has granted approval for Takeda's dengue vaccine, marking the first such authorization in the country. The move aims to address the significant public health burden of dengue fever, though the specific rollout timeline and distribution strategy remain to be clarified.